Association between laboratory markers and presence of coronary artery disease

Vladimir Kincl1, Roman Panovsky, Jaroslav Meluzin

  • 1Ist Department of Internal Medicine-Cardioangiology, St. Ann Faculty Hospital, Masaryk University and International, Clinical Research Center, Brno, Czech Republic. vladimir.kincl@fnusa.cz

Insights

Laboratory markers like leukocyte count, CRP, triglycerides, and uric acid are linked to acute and chronic coronary artery disease (CAD). Fibrinogen and creatinine also relate to atherosclerosis presence.

Area of Science:

  • Cardiology
  • Clinical Chemistry
  • Biomarkers

Background:

  • Coronary artery disease (CAD) poses a significant global health burden.
  • Identifying reliable laboratory markers for CAD diagnosis and risk stratification is crucial.
  • Previous research suggests various biochemical and hematological factors may be associated with CAD.

Purpose of the Study:

  • To investigate the association between specific laboratory markers and the presence and severity of coronary artery disease.
  • To determine which laboratory markers are most predictive of acute and chronic CAD.
  • To explore the relationship between laboratory values and the extent of coronary atherosclerosis.

Main Methods:

  • Prospective study of 1254 patients undergoing coronary angiography for suspected or known CAD.
  • Analysis of fasting blood samples for leukocyte count, C-reactive protein (CRP), fibrinogen, uric acid, creatinine, lipid profile, and glucose.
  • Statistical analysis including ANOVA, chi-square tests, and univariate/multivariate logistic regression.

Main Results:

  • Leukocyte count, CRP, fibrinogen, uric acid, creatinine, HDL cholesterol, triglycerides, and glucose were associated with the presence of acute and chronic CAD.
  • Fibrinogen, creatinine, HDL cholesterol, and glucose influenced the presence of insignificant atherosclerosis.
  • No significant differences in laboratory values were observed between one- and multivessel disease.

Conclusions:

  • Leukocyte count, CRP, triglycerides, and uric acid are associated with both acute and chronic ischemic heart disease.
  • Fibrinogen, creatinine, glucose, and HDL cholesterol are related to the occurrence of insignificant atherosclerosis.
  • These laboratory markers can aid in understanding CAD pathophysiology and risk assessment.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...